Who is sponsoring NCT01512914?

NCT01512914 is sponsored by San Gerardo Hospital.

What condition does NCT01512914 study?

NCT01512914 studies Gynecologic Laparoscopic Surgery.

What drugs are being tested in NCT01512914?

Interventions: Ropivacaine 30 mg, Ropivacaine 30 mg, Ropivacaine 100 mg, saline.

What is the status of NCT01512914?

NCT01512914 is currently COMPLETED.

Last reviewed 2012-01-18 · How we verify

Impact of Intraperitonael Nebulization of Local Anesthetic on Postoperative Pain Associated With Laparoscopic Surgery

NCT01512914 Phase 3 COMPLETED

Studies evaluating intraperitoneal local anesthetic instillation for pain relief after laparoscopic procedures have provided conflicting results. This randomized, double-blind study was designed to assess the effects of a novel intraperitoneal local anesthetic administration technique using nebulization on pain relief after gynecologic laparoscopic surgery.

Details

Lead sponsor	San Gerardo Hospital
Phase	Phase 3
Status	COMPLETED
Enrolment	120
Start date	2008-05
Completion	2009-09

Conditions

Gynecologic Laparoscopic Surgery

Interventions

Ropivacaine 30 mg
Ropivacaine 30 mg
Ropivacaine 100 mg
saline

Primary outcomes

postoperative pain — 24 hours
Postoperative pain was assessed by NRS (0 to 10 points) at rest (static NRS) and after a deep inspiration or cough (dynamic NRS). The proportion of patients with adequate pain control after surgery (dynamic NRS \< 3) will also be assessed.

Countries

Italy